20 LATEST RESOURCES (539 INDEXED)
×
Comparison between Olanzapine and Aripiprazole Treatment for 104 Weeks After Hospital Discharge in Schizophrenia Spectrum Disorders: A Multicenter Retrospective Cohort Study in a Real-World Setting · July 2023
Abstracts
Psychopharmacology
×
Olanzapine as an Add-On, Pre-Operative Anti-Emetic Drug for Postoperative Nausea or Vomiting: A Randomised Controlled Trial · July 2023
Articles
Anaesthesia
×
Effects of Olanzapine on Anhedonia in Schizophrenia: Mediated by Complement Factor H · July 2023
Articles
Frontiers in Psychiatry
×
Effects of Varenicline on the Serum Levels of Olanzapine in Male Patients with Schizophrenia: A Randomized Controlled Trial · May 2023
Articles
Frontiers in Psychiatry
×
Comparison of Olanzapine-Induced Weight Gain and Metabolism Abnormalities between Topiramate and Vitamin C in Patients with Schizophrenia: A Preliminary Study · May 2023
Articles
Frontiers in Psychiatry
×
Does Drug Use Affect the Efficacy of Amisulpride, Aripiprazole and Olanzapine in Patients with Schizophrenia Spectrum Disorders? Results from a Pragmatic, Randomised Study · May 2023
Articles
General Hospital Psychiatry
×
Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial · May 2023
Articles
JAMA Network Open
×
Effects of Low-Dose Combined Olanzapine and Sertraline on Negative and Depressive Symptoms in Treatment-Resistant Outpatients with Acute Exacerbated Schizophrenia · April 2023
Articles
Frontiers in Pharmacology
×
Olanzapine and Weight Loss in Early-Onset Schizophrenia · April 2023
Articles
Primary Care Companion for CNS Disorders
×
Genomic Investigation of Remission and Relapse of Psychotic Depression Treated with Sertraline plus Olanzapine: The STOP-PD II Study · April 2023
Articles
Neuropsychobiology
×
Vitamin D Supplementation Is Effective for Olanzapine-Induced Dyslipidemia · February 2023
Articles
Frontiers in Pharmacology
×
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Olanzapine Plus Triple Antiemetic Regimen for the Prevention of Multiday Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (OFFER Study) · December 2022
Articles
eClinicalMedicine
×
Efficacy of Olanzapine in Anxiety Dimension of Schizophrenia: A Systematic Review of Randomized Controlled Trials · November 2022
Articles
Clinical Psychopharmacology and Neuroscience
×
Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients with Schizophrenia Based on Therapeutic Drug Monitoring Data · November 2022
Abstracts
Journal of Clinical Psychopharmacology
×
Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug · October 2022
Articles
Current Oncology
×
Reduction in Multiple Cardiometabolic Risk Factors with Combined Olanzapine/Samidorphan Compared with Olanzapine: Post Hoc Analyses from a 24-Week Phase 3 Study · October 2022
Articles
Schizophrenia Bulletin